A role for T helper cells in anti-CTLA-4 therapy.

Sci Immunol

Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.

Published: September 2017


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Comparison of immune responses to CTLA4 and PD-1 blockade uncovers a role for helper T cells in anti-CTLA-4 therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1126/sciimmunol.aao6871DOI Listing

Publication Analysis

Top Keywords

role helper
8
helper cells
8
cells anti-ctla-4
8
anti-ctla-4 therapy
8
therapy comparison
4
comparison immune
4
immune responses
4
responses ctla4
4
ctla4 pd-1
4
pd-1 blockade
4

Similar Publications

Copper oxide nanoparticles (CuONPs) are increasingly used across various industrial applications, raising concerns about their potential toxicity and necessitating comprehensive safety evaluations. In this study, we first evaluated the respiratory toxicity of CuONP exposure in a mouse model of asthma. CuONP exposure alone exacerbated asthma symptoms, as evidenced by increased airway hyperresponsiveness, inflammatory cell infiltration, and elevated cytokine production with increasing thioredoxin-interacting protein (TXNIP) expression.

View Article and Find Full Text PDF

T cells play an important role in initiating antibody responses by instructive signals of cell-cell contacts and secretion of soluble cytokines as mediators. We investigated the role of the modified soluble E2 (sE2) antigen from hepatitis C virus (HCV) on healthy human peripheral blood mononuclear cell (PBMC)-derived immune cells or immunized mouse cells to understand the mechanisms of immune regulation by the candidate vaccine antigen. HCV E2 and E2 displayed a role in inducing type 17 T-helper cell (Th17) phenotype, as indicated by interleukin-17 (IL-17) expression and signal transducer and activator of transcription 3 (Stat3) phosphorylation.

View Article and Find Full Text PDF

Background: CD4 T cells play a critical role in the positive and negative regulation of cellular immunity through the many functional subsets they comprise. The progressive growth of immunogenic tumors which nonetheless generate mutation-specific T cells suggests that effective immune control may be avoided or suppressed at the level of the neoantigen-specific CD4 T-cell response. Despite their importance, little is known about the ontogeny, architecture, and development of the CD4 NeoAg-specific repertoire induced by progressively growing tumor.

View Article and Find Full Text PDF

Leishmaniasis is a vector-borne parasitic disease caused by Leishmania spp., for which there is no vaccine and an urgent need for better drugs. The zinc metalloprotease gp63 of Leishmania has been identified as an antigenic structure for vaccine design and a promising target for new antileishmanial agents.

View Article and Find Full Text PDF